News & Updates

Show Multimedia Only
Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

30 Apr 2024 byMike Ng

Treating COVID-19 patients who had been vaccinated or did not have risk factors for severe disease with ritonavir-boosted nirmatrelvir (nirmatrelvir–ritonavir) did not expedite the time to symptom alleviation, reported investigators in the EPIC-SR trial.

Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

30 Apr 2024
Supplement cocktail boosts COVID-19 treatment arsenal

Supplement cocktail boosts COVID-19 treatment arsenal

29 Apr 2024
Vertical COVID-19 transmission low in SG

Vertical COVID-19 transmission low in SG

26 Apr 2024 byAudrey Abella

Transmission of SARS-CoV-2 infection from mothers to newborns appears to be rare in a cohort study conducted by the KK Women’s and Children’s Hospital (KKH), Singapore General Hospital (SGH), and National University Hospital (NUH).

Vertical COVID-19 transmission low in SG

26 Apr 2024
Otitis media cases in China require more attention

Otitis media cases in China require more attention

24 Apr 2024

A recent systematic review and meta-analysis reveals a considerable burden of otitis media (OM) in China that is often overlooked. At present, the most common bacterial pathogen identified is Streptococcus pneumoniae (S pneumoniae).

Otitis media cases in China require more attention

24 Apr 2024